Extracellular DJ-1 induces sterile inflammation in the ischemic brain

Koutarou Nakamura1,2,3, Seiichiro Sakai1,2, Jun Tsuyama1,2

  • 1Stroke Renaissance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

Plos Biology
|May 20, 2021
PubMed

Insights

DJ-1 protein, released from dead cells, acts as a damage-associated molecular pattern (DAMP) that triggers inflammation. Neutralizing extracellular DJ-1 reduced inflammation and damage in ischemic stroke models, suggesting it as a therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Inflammation plays a key role in various diseases, including brain pathologies.
  • DJ-1 is an intracellular antioxidant protein with a newly identified extracellular function.
  • Damage-associated molecular patterns (DAMPs) signal cellular damage and initiate inflammatory responses.

Purpose of the Study:

  • To investigate the role of DJ-1 as a damage-associated molecular pattern (DAMP) in inflammation.
  • To identify the mechanism by which DJ-1 triggers inflammation.
  • To evaluate the therapeutic potential of targeting extracellular DJ-1 in cerebral injury.

Main Methods:

  • Recombinant DJ-1 protein was used to stimulate bone marrow-derived macrophages (BMMs) and dendritic cells (BMDCs) to assess cytokine production.
  • A specific peptide sequence in DJ-1 was identified for its ability to activate Toll-like receptor 2 (TLR2) and TLR4.
  • A murine model of middle cerebral artery occlusion (MCAO) was used to study DJ-1 release, immune cell infiltration, and the effects of DJ-1 neutralization via antibody administration.

Main Results:

  • Extracellular DJ-1 induced the production of inflammatory cytokines in immune cells.
  • A peptide sequence in DJ-1's αG and αH helices was found to activate TLR2 and TLR4.
  • In MCAO models, DJ-1 was released from necrotic neurons and interacted with TLR2 and TLR4 on infiltrating myeloid cells.
  • DJ-1 deficiency reduced inflammatory cytokine expression in immune cells post-stroke.
  • Antibody-mediated neutralization of extracellular DJ-1 suppressed post-ischemic inflammation and attenuated neuronal damage.

Conclusions:

  • DJ-1 functions as a damage-associated molecular pattern (DAMP) that promotes inflammation when released extracellularly.
  • Extracellular DJ-1 activates TLR2 and TLR4, contributing to neuroinflammation after ischemic stroke.
  • Targeting extracellular DJ-1 represents a potential therapeutic strategy for mitigating inflammation in tissue injuries and neurodegenerative diseases.

Related Concept Videos

Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...